Nurse Practitioner · Bismarck, ND
NPI
1962424440
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1421 Mapleton Ave
Bismarck, ND, 58503
Phone (701) 877-1577
Groups this clinician bills Medicare through
Medicare paid, 2024
$731K
10,384 services
Medicare patients, 2024
743
Average age 74
Drug cost, 2024
$148K
928 prescriptions
Company payments, 2025
$884
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin P Chaussee was code J3245 (injection, tildrakizumab, 1 mg), 5,600 times for 18 patients. In total Kevin P Chaussee billed 10,384 services in 47 codes, and Medicare paid $731K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3245 Injection, tildrakizumab, 1 mg | Office | 5,600 | 18 | $107.33 | $601K |
| 17003 Destruction Skin Lesion | Office | 2,318 | 412 | $3.85 | $8,920 |
| 17000 Destruction Skin Lesion | Office | 595 | 480 | $32.41 | $19K |
| 99212 Office E&M - Established | Office | 396 | 329 | $30.43 | $12K |
| 99213 Office E&M - Established | Office | 377 | 320 | $49.57 | $19K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 166 | 25 | $0.64 | $106 |
| 99214 Office E&M - Established | Office | 162 | 132 | $72.68 | $12K |
| 11102 Skin Biopsy | Office | 154 | 130 | $56.90 | $8,762 |
| 17004 Destruction Skin Lesion | Office | 131 | 93 | $90.90 | $12K |
| 96372 Injection Administration | Office | 90 | 35 | $7.54 | $678 |
| 17110 Destruction Skin Lesion | Office | 87 | 81 | $55.41 | $4,821 |
| J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 42 | 39 | $310.57 | $13K |
| 96574 Skin | Office | 42 | 39 | $181.97 | $7,643 |
| 11103 Skin Biopsy | Office | 34 | 28 | $32.75 | $1,113 |
| 11401 Skin Lesion Excision | Office | 27 | 22 | $81.14 | $2,191 |
By year: 2022 $544K for 8,338 services; 2023 $606K for 8,842 services; 2024 $731K for 10,384 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kevin P Chaussee prescribed most often to Medicare patients was Triamcinolone Acetonide, with 164 prescriptions and refills. In total Kevin P Chaussee wrote 928 Medicare prescriptions that cost $148K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 164 | 196 | 125 | $1,241 |
| Ketoconazole Generic | 152 | 191 | 73 | $2,736 |
| Doxycycline Monohydrate Generic | 146 | 239 | 52 | $3,971 |
| Spironolactone Generic | 76 | 168 | 18 | $1,191 |
| Hydrocortisone Generic | 58 | 58 | 38 | $241 |
| Fluocinonide Generic | 55 | 64 | 33 | $2,013 |
| Clindamycin Phosphate Generic | 35 | 36 | 27 | $1,023 |
| Clobetasol Propionate Generic | 28 | 29 | 20 | $1,226 |
| Metronidazole Generic | 25 | 27 | 20 | $1,047 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 21 | 21 | 21 | $233 |
| Ciclopirox Generic | 14 | 14 | Under 11 | $376 |
| Tri-Estarylla Norgestimate-Ethinyl Estradiol | 13 | 13 | Under 11 | $229 |
| Valacyclovir Valacyclovir Hcl | 12 | 14 | Under 11 | $92.78 |
| Fluorouracil Generic | 11 | 11 | Under 11 | $477 |
Brand drugs: 27 claims; generic drugs: 901 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin P Chaussee $884 ($884 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $169.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 17 | $169 |
| E.R. Squibb & Sons, L.L.C. BMY | 14 | $167 |
| Lilly USA, LLC LLY | 19 | $147 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $99.99 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $84.06 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $78.05 |
| Janssen Biotech, Inc. JNJ | 3 | $51.08 |
| UCB, Inc. UCB.BR | 1 | $36.26 |
| Amgen Inc. AMGN | 2 | $29.72 |
| Genzyme Corporation SNY | 1 | $20.92 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.